Selenomethionine Improves Mitochondrial Function by Upregulating Mitochondrial Selenoprotein in a Model of Alzheimer’s Disease

Alzheimer’s disease (AD), the most common neurodegenerative disease in elderly humans, is pathologically characterized by amyloid plaques and neurofibrillary tangles. Mitochondrial dysfunction that occurs in the early stages of AD, which includes dysfunction in mitochondrial generation and energy me...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chen Chen, Yao Chen, Zhong-Hao Zhang, Shi-Zheng Jia, Yu-Bin Chen, Shao-Ling Huang, Xin-Wen Xu, Guo-Li Song
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-10-01
coleção:	Frontiers in Aging Neuroscience
Assuntos:	selenomethionine mitochondrial selenoprotein Alzheimer’s disease mitochondria dysfunction and dementia therapeutic effect and mechanism
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fnagi.2021.750921/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!